Sign In
Buy CLVT
$1.91
-0.130 (-6.37%)
At Close: Jun 22, 2026
Clarivate: The Cheapest AI Stock Worth Buying?
10:03am, Wednesday, 03'rd Jul 2024
Clarivate NYSE: CLVT may not be the cheapest AI stock worth buying, but it is inexpensive and set up to rebound strongly over the next few quarters. Trading at a mere 7.5x its earnings outlook for 202
Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities
03:00am, Tuesday, 02'nd Jul 2024
New report highlights challenges and opportunities in resilient MedTech industry LONDON , July 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intellig
Clarivate Report Demonstrates Societal Impact of Digital Health Research and Innovation Growth
06:15am, Thursday, 27'th Jun 2024
LONDON , June 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released a Global Research Report from the Institute for Scientif
Top 5 Stocks to Watch for AI-Driven Gains That Aren't NVIDIA
10:54am, Monday, 24'th Jun 2024
Goldman Sachs NYSE: GS released a list of their top 50 stocks based on expected AI-driven earnings leverage. The firm ranked companies across sectors according to forecasted productivity gains linked
Clarivate Launches IP Collaboration Hub
03:00am, Monday, 24'th Jun 2024
Enabling users to save time and reduce risks in the IP filing and prosecution process LONDON , June 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative i
Clarivate Reveals World's Leading and Trusted Journals with the 2024 Journal Citation Reports
03:00am, Thursday, 20'th Jun 2024
Adds Emerging Sources Citation Index™ for a simplified and unified category view LONDON , June 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intell
Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report
03:00am, Wednesday, 19'th Jun 2024
Emerging standouts set to transform drug discovery and development, revolutionize cancer treatment, and capture big pharma interest highlighted in third annual report LONDON , June 19, 2024 /PRNewswir
Clarivate Launches Research Horizon Navigator to Pinpoint Future Breakthrough Areas
03:00am, Tuesday, 04'th Jun 2024
Insights from the new InCites Benchmarking & Analytics module support strategic investment and demonstrate impact LONDON , June 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global p
Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from HealthWise Data
03:00am, Friday, 31'st May 2024
Strategic collaboration enhances insight into patient demographics and behaviors, enabling analytical precision in addressing population health outcomes LONDON, May 31, 2024 /PRNewswire/ -- Clarivate
Clarivate Announces Conversion Date and Conversion Rate for Series A Mandatory Convertible Preferred Shares
05:12pm, Thursday, 30'th May 2024
LONDON , May 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PR A) ("Clarivate"), a leading global provider of transformative intelligence, announced today that its 5.25% Series A Mandatory C
Clarivate Plc: Still A Buy, But Recovery Could Take Longer Than Expected
02:32pm, Thursday, 30'th May 2024
Clarivate reported weak 1Q24 results, with revenue falling and organic growth dipping into negative territory. Despite the disappointing results, I still believe Clarivate is an attractive buy, as the
Clarivate Celebrates 500 Institutions Adopting Rialto Marketplace Solution
03:00am, Thursday, 30'th May 2024
Transforming the way libraries select, acquire and manage their collections of academic books LONDON , May 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformat
Clarivate to Present at Upcoming Investor Conferences in June 2024
09:15am, Wednesday, 29'th May 2024
LONDON , May 29, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that the Company will present
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024
03:00am, Wednesday, 22'nd May 2024
New report highlights innovations poised to drive significant clinical and market impact LONDON , May 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative i
New Clarivate Report Indicates Solid Growth in 2024 Global Trademark Filing Activity
03:00am, Tuesday, 21'st May 2024
Analyzing six of the key trademark registers from around the world LONDON , May 21, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today re
